Developed by ImmunoAct, IIT Bombay and Tata Memorial Hospital, the therapy has been administered to 15 patients in India. Three of them have successfully achieved cancer remission. Dr Gupta, the first commercial patient to be declared free of cancer, speaks of his experience exclusively to The Indian Express